Cite
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
MLA
Parker, Scott, et al. “Co-Administration of the Broad-Spectrum Antiviral, Brincidofovir (CMX001), with Smallpox Vaccine Does Not Compromise Vaccine Protection in Mice Challenged with Ectromelia Virus.” Antiviral Research, vol. 111, Nov. 2014, pp. 42–52. EBSCOhost, https://doi.org/10.1016/j.antiviral.2014.08.003.
APA
Parker, S., Crump, R., Foster, S., Hartzler, H., Hembrador, E., Lanier, E. R., Painter, G., Schriewer, J., Trost, L. C., & Buller, R. M. (2014). Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus. Antiviral Research, 111, 42–52. https://doi.org/10.1016/j.antiviral.2014.08.003
Chicago
Parker, Scott, Ryan Crump, Scott Foster, Hollyce Hartzler, Ed Hembrador, E Randall Lanier, George Painter, Jill Schriewer, Lawrence C Trost, and R Mark Buller. 2014. “Co-Administration of the Broad-Spectrum Antiviral, Brincidofovir (CMX001), with Smallpox Vaccine Does Not Compromise Vaccine Protection in Mice Challenged with Ectromelia Virus.” Antiviral Research 111 (November): 42–52. doi:10.1016/j.antiviral.2014.08.003.